Fundz

Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer • Solid Biosciences

PUBLIC · SLDBOct 02, 2023

Position

Chief Medical Officer

Company

Solid Biosciences

Gabriel Brooks
CharlestownBiotechnologyHealthcareHealth CareGeneticsTherapeutics

Description

CHARLESTOWN, Mass., Oct. 02, 2023 -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for both neuromuscular and cardiac diseases, today announced the appointment of Gabriel Brooks, M.D., as Chief Medical Officer.

Quick answer

Solid Biosciences Appoints Gabriel Brooks, M.D., as Chief Medical Officer • Solid Biosciences (October 2, 2023). Solid Biosciences is based in Charlestown, Massachusetts, United States.

Who is the new Chief Medical Officer at Solid Biosciences?
Solid Biosciences named Gabriel Brooks Chief Medical Officer, announced October 2, 2023.
What did Solid Biosciences announce on October 2, 2023?
CHARLESTOWN, Mass., Oct. 02, 2023 -- Solid Biosciences Inc. , a life sciences company developing precision genetic medicines for both neuromuscular and cardiac diseases, today announced the appointment of Gabriel Brooks, M.D., as Chief Medical Officer.
What does Solid Biosciences do?
Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates and neuromuscular and cardiac programs, including SGT-003, for the treatment of Duchenne muscular dystrophy...
Where is Solid Biosciences based?
Solid Biosciences is based in Charlestown, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Madrigal Pharmaceuticals (September 14, 2023), 4D Molecular Therapeutics (September 12, 2023), DermTech, Inc. (September 11, 2023) and Q32 Bio (October 24, 2023) also announced leadership changes within 45 days of Solid Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Genetics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Solid Biosciences, and when

A new leader at Solid Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Solid Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Solid Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Solid Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Solid Biosciences

Location

500 RUTHERFORD AVENUE

Charlestown, Massachusetts, United States

About

Solid Biosciences is a life sciences company focused on advancing a portfolio of gene therapy candidates and neuromuscular and cardiac programs, including SGT-003, for the treatment of Duchenne muscular dystrophy (Duchenne), SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy, AVB-202-TT for the treatment of Friedreich’s ataxia, and additional assets for the treatment of fatal cardiac diseases. Solid is advancing its diverse pipeline across rare neuromuscular and cardiac diseases, bringing together experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted, Solid’s mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit www.solidbio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Solid Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Solid Biosciences's next move

Learn about Strategic plan

Solid Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.